Prophylactic cranial irradiation improved the overall survival of patients with surgically resected small cell lung cancer, but not for stage I disease
Autor: | Li Kong, Hongbo Guo, Fang Shi, Kunli Zhu, Jingming Yu, Xibin Liu, Jingyu Luo, Hui Zhu |
---|---|
Rok vydání: | 2014 |
Předmět: |
Adult
Male Pulmonary and Respiratory Medicine Cancer Research medicine.medical_specialty Disease PTNM stage Overall survival medicine Humans cardiovascular diseases Lung cancer Aged Retrospective Studies Aged 80 and over Brain Neoplasms business.industry Retrospective cohort study Middle Aged Prognosis medicine.disease Combined Modality Therapy Small Cell Lung Carcinoma Surgery Survival Rate surgical procedures operative Oncology Conventional PCI Female Non small cell Cranial Irradiation Prophylactic cranial irradiation business therapeutics |
Zdroj: | Lung Cancer. 86:334-338 |
ISSN: | 0169-5002 |
DOI: | 10.1016/j.lungcan.2014.09.019 |
Popis: | Objectives We conducted a retrospective study to evaluate the role of prophylactic cranial irradiation (PCI) on patients with surgically resected small cell lung cancer (SCLC). Patients and methods Between January 2003 and December 2009, the records of completely resected patients who were diagnosed with SCLC and definitive pTNM stage on the basis of histological proof were reviewed. According to the therapy modality, patients were allocated to PCI group and non-PCI group. Results A total of 193 patients were finally included, 67 patients in PCI group and 126 in non-PCI group. The OS rates at 2-year and 5-year in PCI group were 92.5%, and 54.9%, respectively, and those of non-PCI were 63.2% and 47.8%, respectively ( p =0.005). The BMFS rate at 2-year and 5-year in PCI group was significantly better than those of non-PCI group (96.8%, 76.6% and 79.4%, 75.5%, respectively, p =0.014). But PCI could not confer survival benefit in the patients with p-stage I. Multivariate analysis revealed that PCI (HR=2.339; p =0.001) was an independent prognostic factor of the overall survival. Conclusions PCI could improve the OS of patients with surgically resected SCLC, but not for p-stage I patients. |
Databáze: | OpenAIRE |
Externí odkaz: |